贝尔的最佳治疗:类固醇,抗病毒药物,及时和个性化的方法
Hwa Sung Rim1, Jae Yong Byun1, Sang Hoon Kim1
1Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Kyung Hee University Medical Center, Seoul 02447, Republic of Korea.
Journal of clinical medicine
|January 11, 2024
概括
在72小时内开始的类固醇单疗法为贝尔患者提供了最佳的恢复. 虽然联合治疗可能有利于严重病例,但早期的类固醇治疗是最佳结果的关键.
科学领域:
- 神经学 神经学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝尔,以急性异常性面部神经麻为特征,呈现了一个不清楚的最佳治疗策略.
- 目前的管理辩论涉及类固醇单一疗法与联合类固醇和抗病毒疗法,以及最佳治疗开始时间.
研究的目的:
- 评估治疗方式 (单独使用类固醇与类固醇加抗病毒药物) 和时间对贝尔的恢复率的影响.
- 为了确定影响患者从贝尔麻中恢复的个别因素.
主要方法:
- 对1504名贝尔麻患者的回顾性分析.
- 根据治疗分类的患者:类固醇单一疗法与联合疗法.
- 分析了治疗开始时间:在72小时内 vs 72小时后.
主要成果:
- 在72小时内开始的类固醇单一治疗显示出最高的康复率 (86.32% vs. 79.25%的联合治疗).
- 在72小时后开始的治疗显示了较高的恢复率 (85.69%) 与在72小时内 (76.92%).
- 年龄较小 (20-39岁) 和良好的EMG结果与明显更高的康复率有关.
结论:
- 个性化治疗对于贝尔的治疗至关重要.
- 早期的类固醇单疗法 (72小时内) 是有效的,在严重病例中,结合疗法具有潜在的益处.
- 需要进一步的研究来验证这些发现,并完善治疗指南,考虑到患者因素和研究局限性.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Tonsillitis II: Management
114
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
114
Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
Flail Chest-II
174
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
174
Skeletal Muscle Relaxants: Therapeutic Uses
487
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
487


